NEWS
PureHealth moves into UK with Unilabs acquisition
International private health firm PureHealth has announced the expansion of its platform into laboratory operations across the UK, with its Circle Health Group subsidiary taking over Unilabs’ existing UK operations. Circle Health Group will assume
selected UK laboratory operations from Unilabs, including two dedicated hub laboratories in Euston and Cavendish Square, London, supported by a network of fully licensed laboratories across the UK. The integrated diagnostics capabilities will strengthen the group’s services across a network of more than 50 hospitals. Together, the laboratories provide pathology, histopathology, blood sciences, microbiology, and specialist diagnostic services, serving an established base of more than 90 external healthcare clients. The expansion will utilise the expertise
of PureLab, part of PureHealth and the UAE’s largest laboratory operator, which manages a network of more than 150 laboratories across the country and processes over 25 million tests annually.
PureLab is supported by advanced automation, AI-enabled diagnostics, and internationally accredited laboratory operations, providing proven clinical, operational, and technological expertise to PureHealth platforms. Shaista Asif, Group Chief Executive
Officer of PureHealth, said: “This expansion demonstrates how we create greater value by connecting expertise across our international portfolio. By utilising PureLab’s proven diagnostics capabilities across Circle Health Group’s leading hospital network, we are creating an integrated model that strengthens every stage of the patient journey, from diagnosis through to treatment. Circle Health Group’s existing
clinical activity provides an established foundation of laboratory volumes from day one, with additional eligible volumes expected to transition over time. Alongside supporting the group’s hospitals, the laboratory network will continue to provide high-quality diagnostic services to its existing external healthcare clients across the UK.
Roche opens Innovation Center Boston
Roche has hosted the grand opening of the Roche Genentech Innovation Center Boston, expanding Roche and Genentech’s US research presence in one of the world’s leading life sciences communities. Located at Harvard’s Enterprise
Research Campus in Allston, the facility will serve as Roche’s Cardiovascular, Renal and Metabolism (CVRM) hub, establishing a significant end-to-end research and development presence in CVRM. With the new site, Roche and
Genentech are expanding their footprint within the Greater Boston innovation ecosystem, leveraging local talent and anchoring an entrepreneurial hub at Harvard’s Enterprise Research Campus. It brings together scientists from across discovery research, clinical development, artificial intelligence and data science disciplines, and creates an end-to-end research environment spanning early- stage discovery through late-stage clinical development. The Innovation Center is part of Roche
and Genentech’s investment commitment in US manufacturing and R&D and builds on recent investments and manufacturing milestones in Holly Springs, North Carolina, and Hillsboro, Oregon. Together, these investments expand an end-to- end US footprint spanning research, development and manufacturing and reflect the companies’ long-term commitment to American scientific innovation. Roche and Genentech have around 25,000 employees in the United States, with 15 R&D centres and 13 manufacturing sites across Pharma and Diagnostics.
October 2026
WWW.PATHOLOGYINPRACTICE.COM 11
Tishman Speyer
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56
